Member Info for Brand

P2 results, first P3 patient dosed and a fat us govt grant would be a great Xmas present ;-)

Fruits I agree with everything you just said, but America is a little bit special. Hop on to YouTube and search 'american pharmaceutical ads' - it's an eye opener

This is also why SSH and RM being on WebMD is such a big deal. WebMD is where Americans go to self diagnose and obsess over minor ailments. Unless you have the most gold plated of insurance plans, there's a good chance a trip to the GP will leave you out of pocket.

These interviews are not just speaking to the American medical establishment or investors, they are speaking directly to the American public.

I suspect this is why we are on A2P3 as an early administration candidate, even tho INFb 'wants a fire to put out' and the high cost - if it works (and we know it does :), the yanks will demand it, as soon as they test positive. (Imho)

Ghia, I completely agree with the sentiment of your comment re exposure and volatility, but I think it's worth remembering that in the US, patients have a lot more choice in their treatment. If SNG makes the breakthrough in to the mainstream as 'the best cure for Covid' those same patients will be driving the demand for the big fat orders....

Ok Champ (thumbs up)

She's a one woman SNG marketing campaign on twitter as well. Relentless :)

Seen a new Numis Note for sng kicking around on twitter. Can anyone confirm?

https://twitter.com/AIMdective/status/1471095830924992515?t=pMWzMn6DpGgN5WGAKeQnFw&s=19

Absolutely nothing more than a bit of speculation, but am gonna say 11am this morning or tomorrow. Obvs this isn't based on any data or knowledge, just have a funny feeling...

Watch the last 30 seconds or so back, Dr Whitesmile is congratulating SSH and the knight has a wide a grin as you'll ever see on his face. Whitesmile then says 'for being 'Knighted by the Queen' and SSH quickly remembers the script ;-)

He wasn't speaking to you, he was speaking to the US medical professional market and American general public.

https://www.fiercebiotech.com/biotech/tidy-up-your-labs-biotech-pfizer-coming-significant-firepower-and-cash-to-burn

'And don’t rule out a blockbuster deal just yet: Malik said that if a larger opportunity comes up, Pfizer is willing to pounce. Several large transactions, at $50 billion or more, are likely to occur next year, PwC predicted last week.

“If we see a larger acquisition opportunity that is strategic and we deem as value-creating, we certainly have the very solid balance sheet we can utilize to pursue that,” Malik said. “We will not speak in absolutes, and we never say never because we know circumstances can change.”

At Matml offered in an earlier post, Pfizer expecting 22b in sales for the covid pill in 2022 alone... it may take a few steps up the ladder to get to true value but this is gonna be huge.

Nice one thanks guys. Lets see how high we bounce off 200 here...

What are our resistance points? I'm not trading I just want to cheer for the sp to break em.

Recall 207 from a couple weeks back which we seem to be challenging atm.

Why would you give your product to big pharma when you can be big pharma?

Dr whitesmile's 'listening eyebrows' are exceptional

Watch this, shared yesterday by brilliant poster Matml :)

https://www.webmd.com/coronavirus-in-context/video/stephen-holgate

Reckon RM is getting a big white hat fitted ready for the interview later this week?

Tbh I don't know. I tipped off a few mates back home (Canada) on SNG and they said they wouldn't touch octa w a ten foot pole.

It does, but I understand it's not exactly in prime real estate

https://www.google.com/search?q=sygff&client=ms-android-google&sxsrf=AOaemvJgdYKGWAlvah23vG93--xE1ltGlA%3A1639488876770&ei=bJ24Yeu9LvWDhbIPw9WGMA&oq=sygff&gs_lcp=ChNtb2JpbGUtZ3dzLXdpei1zZXJwEAEYADIECCMQJzoHCCMQsAMQJzoHCAAQRxCwAzoQCC4QsQMQsQMQxwEQ0QMQCjoFCAAQgAQ6BwguEIAEEAo6CwguEIAEEMcBEK8BOgUILhCABDoKCAAQsQMQyQMQCjoFCAAQkgM6DgguEIAEELEDEMcBEK8BOggIABCABBCxAzoICC4QgAQQsQM6BQgAEJECOgsIABCABBCxAxCDAToOCC4QgAQQsQMQxwEQowI6CgguEMcBEKMCECc6CwguEMcBEK8BEJECOggIABCxAxCDAToKCAAQgAQQhwIQFDoLCC4QgAQQxwEQ0QM6BwguELEDEAo6BwgAELEDEAo6BAguEAo6BAgAEApKBAhBGABQlQpYnh5gkCloAXABeACAAd4BiAHjCJIBBTEuNi4xmAEAoAEByAEJwAEB&sclient=mobile-gws-wiz-serp

A question for those that know their stocks and shares...

From stateside feedback, I understand the 'octa markets' that hosts SYGFF is pretty undesirable for US investors

Given its the US market we are after, would it make sense for SNG to dual list on the NYSE? Is a practical move?